Chelsea is a strategic thinker, who advises organisations about how to implement AI and other emerging technologies to achieve legally sound, commercial and strategic outcomes.

As a Legal Lead in MinterEllison's AI Advisory practice, Chelsea guides boards and executive teams on AI governance frameworks, Responsible AI implementation and regulatory compliance. She supports clients in developing privacy and contract settings that protect personal information and intellectual property and align with AI risk management and ESG obligations. Chelsea advises ASX-listed companies and government across regulated sectors, including healthcare, education and financial services.

Chelsea also serves as the Australian Ambassador for the Global Council of Responsible AI, reflecting her leadership in shaping AI ethics, policy and best-practice governance.

Career highlights

• Developed AI governance programs for various large international and national healthcare providers, addressing fragmented AI adoption, regulatory uncertainty, and operational risk across multiple jurisdictions via board, executive, and stakeholder engagement and the design and delivery of key responsible AI policies and processes.
• Advised a national private equity firm on Responsible AI governance and disclosure obligations, as well as legal and ethical standards applicable to its portfolio companies across sectors including financial services, healthcare, and education.
• Advised national education providers on responsible AI use in learning environments, including managing risks associated with vulnerable users such as children acting as AI deployers.
• Provided privacy advice to multiple ASX-listed companies, large government departments and state corporations, including with a focus on safe and responsible artificial intelligence adoption.
• Drafted AI procurement terms for large government departments.
• Advised Local Health Districts in NSW and Hospital and Health Services in Queensland about how to create appropriate settings to enable appropriate privacy settings for the use of data for research and commercialisation.
• Lead and advised various government departments across Australia in relation to large government contracts to improve accessibility to vital health services, including hospitals, urgent care and cancer treatment centres.
• Advised several clients in relation to complex healthcare regulatory issues, including TGA advertising compliance, anti kick-back laws and health funding laws.
• Advised several clients in relation to AI policies and assurance activities.
• Advised government, local private entities and in bound investors into the healthcare sector on a range of issues including regulation of dangerous drugs, regulation of diagnostic imaging and pathology businesses, compliance with TGA registration requirements and advertising restrictions.
• Negotiated agreements and advised in relation to legal risks arising from research and clinical trial arrangements.

• eSafety Commissioner issues notices to 4 AI companies
  

  Australia's eSafety Commissioner has issued legal notices to 4 AI companion companies: Character Technologies, Inc., Glimpse.AI, Chai Research Corp, and Chub AI Inc.

• Continuing the conversation: top cyber and privacy questions answered
  

  Your top questions from our fireside discussion between Paul Kallenbach and Australian Privacy Commissioner Carly Kind about privacy, cyber risk, artificial intelligence and data governance.

• Australia introduces a national AI plan: Four things leaders need to know
  

  Australia has released its long-awaited National AI Plan. This article outlines the Plan and what ers should prioritise next. 

• Procuring AI: Key considerations and strategies
  

  As AI becomes central to business operations, this guide helps organisations navigate the legal, ethical and practical risks of AI procurement.

• Mandatory safety guardrails foreshadowed for high-risk AI
  

  We explore the implications of the Australian Government's recently published 'Safe and responsible AI in Australia consultation interim response'.

• Branching out: Ahpra publishes cannabis prescriber guidance
  

  On 9 July 2025, Ahpra published guidance on medicinal cannabis prescribing. We summarise 5 key takeaways for prescribers and provide additional guidance for medicinal cannabis businesses.

• Increased AI regulation? Final Senate Report key takeaways
  

  The Senate Select Committee on Adopting Artificial Intelligence has delivered its final report, signalling a clear direction for regulation in Australia.

• Responsible use of AI: New Australian guardrails released
  

  We explore the Australian Government's two newly released publications to guide the development and deployment of AI in Australia.

• National Framework for the Assurance of AI in Government
  

  Federal, state and territory governments have released a new National Framework for the Assurance of Artificial Intelligence in Government.

• OAIC privacy guidance for AI developers
  

  On October 21 2024, the Office of the Australian Information Commissioner (OAIC) published privacy guidance for 'developers' of artificial intelligence (AI) that are subject to the Privacy Act 1988 (Cth) (Privacy Act).

• Ahpra introduces AI guidance for health practitioners
  

  Ahpra recently published guidance outlining how health practitioners can meet their existing professional obligations when using artificial intelligence (AI)

• Innovation meets regulation: Medical devices and artificial intelligence
  

  When is Artificial Intelligence (AI) in medical devices regulated? This article provides a quick summary of the key things healthcare providers and innovators need to know. It also outlines the key implications of updated guidance by the Therapeutic Goods Administration (TGA) on 3 July 2024.

• Taking responsibility: Guardrails for high-risk AI
  

  The Australian Government has recognised that our current regulatory system is not fit for purpose to respond to the distinct risks that AI poses.

• AICD and Governance Institute: AI in minute-taking
  

  Explore the latest overview of the key issues and questions for Boards and companies to consider in relation to AI assisted minute preparation.

• Entering the future: Use of AI in the healthcare sector
  

  How are healthcare providers actually using AI? Here is a brief survey of the market.

• Shared medical record platform in Victoria
  

  This article summarises the changes to the Health Services Act 1988 (Vic)(HSA).